Abstract

ObjectivesTo evaluate initial combination therapy with ambrisentan plus tadalafil (COMB) compared with monotherapy of either agent (MONO), and the utility of baseline characteristics and risk stratification in predicting outcomes, in...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Kombinationstherapie mit Ambrisentan und Tadalafil bei CTD-PAH: viel hilft viel?
Panagiota Xanthouli
Kompass Pneumologie | VOL. 9
Panagiota XanthouliPanagiota Xanthouli
09 Feb 2021
Kombinationstherapie mit Ambrisentan und Tadalafil bei CTD-PAH: Viel hilft viel?
Panagiota Xanthouli
Kompass Autoimmun | VOL. 3
Panagiota XanthouliPanagiota Xanthouli
22 Jan 2021
Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial
John Gerry Coghlan ... Karen L Miller
Annals of the Rheumatic Diseases | VOL. 76
John Gerry Coghlan, et. al.John Gerry Coghlan ... Karen L Miller
30 Dec 2016
Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment.
Clara Hjalmarsson ... Stefan Söderberg
ERJ open research | VOL. 7
Clara Hjalmarsson, et. al.Clara Hjalmarsson ... Stefan Söderberg
22 Apr 2021
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
From fibrositis to fibromyalgia to nociplastic pain: how rheumatology helped get us here and where do we go from here?
Daniel J Clauw
Annals of the Rheumatic Diseases | VOL. -
Daniel J ClauwDaniel J Clauw
06 Aug 2024
Development of international consensus on a standardised image acquisition protocol for diagnostic evaluation of the sacroiliac joints by MRI: an ASAS–SPARTAN collaboration
Robert G W Lambert ... Walter P Maksymowych
Annals of the Rheumatic Diseases | VOL. -
Robert G W Lambert, et. al.Robert G W Lambert ... Walter P Maksymowych
06 Aug 2024
Journey through discovery of 75 years glucocorticoids: evolution of our knowledge of glucocorticoid receptor mechanisms in rheumatic diseases
Ann-Kathrin Eiers ... Jan P Tuckermann
Annals of the Rheumatic Diseases | VOL. -
Ann-Kathrin Eiers, et. al.Ann-Kathrin Eiers ... Jan P Tuckermann
06 Aug 2024
Helicobacter pylori upregulates PAD4 expression via stabilising HIF-1α to exacerbate rheumatoid arthritis
Hui Wu ... Chao Wu
Annals of the Rheumatic Diseases | VOL. -
Hui Wu, et. al.Hui Wu ... Chao Wu
06 Aug 2024
View more papers